Medtronic 2028 increased by 0.1% to $1.56B in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 4.2%, from $1.63B to $1.56B. This increase may warrant attention — for this metric, lower values are generally preferred.
A declining trend in these annual projections indicates that the bank's historical acquisition costs are being successfully absorbed.
This represents the projected amortization expense for finite-lived intangible assets for the year 2028. It reflects the...
Standard disclosure for banks with significant historical acquisition activity.
other_finite_lived_intangible_assets_amortization_expens_398565| Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | Q2 '26 | Q3 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.62B | $1.63B | $1.63B | $1.63B | $1.63B | $1.63B | $1.64B | $1.65B | $1.65B | $1.60B | $1.62B | $1.63B | $1.56B | $1.56B | $1.56B |
| QoQ Change | — | +0.7% | -0.1% | -0.1% | +0.0% | +0.2% | +0.7% | +0.3% | +0.3% | -3.0% | +0.8% | +0.6% | -4.3% | +0.1% | +0.1% |
| YoY Change | — | — | — | +0.5% | -0.2% | +0.1% | +0.9% | +1.2% | +1.3% | -2.4% | -1.9% | -1.6% | -3.0% | -3.7% | -4.2% |